Tech Company Financing Transactions
20/20 GeneSystems Funding Round
Private investors invested in a $2 million capital raise for 20/20 GeneSystems. This venture round was announced on 9/22/2015.
Transaction Overview
Company Name
Announced On
9/22/2015
Transaction Type
Venture Equity
Amount
$2,037,014
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed. SEC regulatory filing. Amount may include options, warrants or other securities. Contact technology company for investment details, if applicable. Not an offer or solicitation for sale of securities or debt.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
9430 Key West Ave. 100
Rockville, MD 20850
USA
Rockville, MD 20850
USA
Phone
Website
Email Address
Overview
20/20 GeneSystems ('20/20') was founded in May of 2000 to develop and promote innovative tools for biotech.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Jonathan Cohen
Browse more venture capital transactions:
Prev: 9/22/2015: Arrayent venture capital transaction
Next: 9/22/2015: Akari Therapeutics venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on tech company VC transactions. VC investment data records reported here are sourced from company press releases and news coverage. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs